David Chisholm

Head Of Technology at LightOx Ltd

David Chisholm has extensive work experience in the field of chemistry and research. David started their career at Durham University as a Postdoctoral Researcher, where they focused on designing and synthesizing bioactive compounds for the treatment of neurodegenerative diseases. During this time, their research led to a patent application, two publications, and the creation of Nevrargenics Ltd. David also supervised the research projects of undergraduate students.

Following their time at Durham University, David joined LightOx Ltd as a Research Chemist. In this role, they established the company's core intellectual property and developed a novel technology for the destruction of cancerous cells. This intellectual property played a crucial role in securing seed investment of over £250k. Additionally, David designed and commercialized a range of research tools called LightOx Probes, which generated sales of over £100k through worldwide distributor Sigma Millipore.

Currently, David serves as the Chemistry Team Leader at LightOx Ltd. David manages a team of three chemists and is responsible for the development of LightOx's photoactive therapy for oral epithelial dysplasia and other research and development programs. David has made significant contributions to the company, including the development of key intellectual property for the oral epithelial dysplasia research and advancing the company through preclinical development.

Overall, David Chisholm's work experience showcases their expertise in chemistry, research, and leadership, as well as their ability to contribute to the advancement of innovative technologies and therapies.

David Chisholm completed their education in a chronological manner. From 2009 to 2013, they attended Durham University and earned a bachelor's degree in Chemistry, graduating with honors. Following this, they pursued further studies at Durham University from 2013 to 2016 and obtained a Doctor of Philosophy (PhD) degree in Biological Chemistry.

In addition to their academic qualifications, David Chisholm has also obtained a PRINCE2® Foundation Certification Training from PRINCE2.com in June 2020.

Location

Newcastle, United Kingdom

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


LightOx Ltd

Lightox has developed a unique range of molecular tools for use in imaging, therapeutics and assay development. These unique probes are smaller than any other commercially available fluorescent product. They offer the option of using our technologies as freely-moving probes that readily incorporate into cells or with a range of flexible linkers togive specificity to your unique applications and research needs.